Literature DB >> 11748186

Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human toll-like receptor 4.

Atsutoshi Yoshimura1, Takashi Kaneko, Yoshifumi Kato, Douglas T Golenbock, Yoshitaka Hara.   

Abstract

Toll-like receptors (TLRs) 2 and 4 have recently been identified as possible signal transducers for various bacterial ligands. To investigate the roles of TLRs in the recognition of periodontopathic bacteria by the innate immune system, a Chinese hamster ovary (CHO) nuclear factor-kappaB (NF-kappaB)-dependent reporter cell line, 7.7, which is defective in both TLR2- and TLR4-dependent signaling pathways was transfected with human CD14 and TLRs. When the transfectants were exposed to freeze-dried periodontopathic bacteria, Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Capnocytophaga ochracea, and Fusobacterium nucleatum, and a non-oral bacterium, Escherichia coli, all species of the bacteria induced NF-kappaB-dependent CD25 expression in 7.7/huTLR2 cells. Although freeze-dried A. actinomycetemcomitans, F. nucleatum, and E. coli also induced CD25 expression in 7.7/huTLR4 cells, freeze-dried P. gingivalis did not. Similarly, lipopolysaccharides (LPS) extracted from A. actinomycetemcomitans, F. nucleatum, and E. coli induced CD25 expression in 7.7/huTLR4 cells, but LPS from P. gingivalis and C. ochracea did not. Furthermore, LPS from P. gingivalis and C. ochracea attenuated CD25 expression in 7.7/huTLR4 cells induced by repurified LPS from E. coli. LPS from P. gingivalis and C. ochracea also inhibited the secretion of interleukin-6 (IL-6) from U373 cells, the secretion of IL-1beta from human peripheral blood mononuclear cells, and ICAM-1 expression in human gingival fibroblasts induced by repurified LPS from E. coli. These findings indicated that LPS from P. gingivalis and C. ochracea worked as antagonists for human TLR4. The antagonistic activity of LPS from these periodontopathic bacteria may be associated with the etiology of periodontal diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11748186      PMCID: PMC127593          DOI: 10.1128/IAI.70.1.218-225.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Toll-like receptors confer responsiveness to lipopolysaccharide from Porphyromonas gingivalis in human gingival fibroblasts.

Authors:  K Tabeta; K Yamazaki; S Akashi; K Miyake; H Kumada; T Umemoto; H Yoshie
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation.

Authors:  A Poltorak; P Ricciardi-Castagnoli; S Citterio; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

3.  Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism.

Authors:  C Werts; R I Tapping; J C Mathison; T H Chuang; V Kravchenko; I Saint Girons; D A Haake; P J Godowski; F Hayashi; A Ozinsky; D M Underhill; C J Kirschning; H Wagner; A Aderem; P S Tobias; R J Ulevitch
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

Review 4.  The role of inflammatory mediators in the pathogenesis of periodontal disease.

Authors:  R C Page
Journal:  J Periodontal Res       Date:  1991-05       Impact factor: 4.419

5.  Immunobiological activities of a chemically synthesized lipid A of Porphyromonas gingivalis.

Authors:  T Ogawa; Y Asai; H Yamamoto; Y Taiji; T Jinno; T Kodama; S Niwata; H Shimauchi; K Ochiai
Journal:  FEMS Immunol Med Microbiol       Date:  2000-08

6.  Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides.

Authors:  R I Tapping; S Akashi; K Miyake; P J Godowski; P S Tobias
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

7.  Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages.

Authors:  M Hirschfeld; J J Weis; V Toshchakov; C A Salkowski; M J Cody; D C Ward; N Qureshi; S M Michalek; S N Vogel
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

8.  Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide.

Authors:  T Ogawa
Journal:  FEBS Lett       Date:  1993-10-11       Impact factor: 4.124

9.  Biochemical and immunobiological properties of lipopolysaccharide (LPS) from Bacteroides gingivalis and comparison with LPS from Escherichia coli.

Authors:  T Koga; T Nishihara; T Fujiwara; T Nisizawa; N Okahashi; T Noguchi; S Hamada
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

10.  Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling.

Authors:  A B Schromm; E Lien; P Henneke; J C Chow; A Yoshimura; H Heine; E Latz; B G Monks; D A Schwartz; K Miyake; D T Golenbock
Journal:  J Exp Med       Date:  2001-07-02       Impact factor: 14.307

View more
  50 in total

1.  VimA-dependent modulation of acetyl coenzyme A levels and lipid A biosynthesis can alter virulence in Porphyromonas gingivalis.

Authors:  A Wilson Aruni; J Lee; D Osbourne; Y Dou; F Roy; A Muthiah; D S Boskovic; H M Fletcher
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  The hemoglobin receptor protein of porphyromonas gingivalis inhibits receptor activator NF-kappaB ligand-induced osteoclastogenesis from bone marrow macrophages.

Authors:  Yuji Fujimura; Hitoshi Hotokezaka; Naoya Ohara; Mariko Naito; Eiko Sakai; Mamiko Yoshimura; Yuka Narita; Hideki Kitaura; Noriaki Yoshida; Koji Nakayama
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease.

Authors:  M Folwaczny; J Glas; H-P Török; O Limbersky; C Folwaczny
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

4.  A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems.

Authors:  Ryosuke Takii; Tomoko Kadowaki; Atsuyo Baba; Takayuki Tsukuba; Kenji Yamamoto
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 5.  Beyond good and evil in the oral cavity: insights into host-microbe relationships derived from transcriptional profiling of gingival cells.

Authors:  M Handfield; H V Baker; R J Lamont
Journal:  J Dent Res       Date:  2008-03       Impact factor: 6.116

Review 6.  Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host.

Authors:  Jennifer L Krauss; Jan Potempa; John D Lambris; George Hajishengallis
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

7.  Synthetic tetra-acylated derivatives of lipid A from Porphyromonas gingivalis are antagonists of human TLR4.

Authors:  Yanghui Zhang; Jidnyasa Gaekwad; Margreet A Wolfert; Geert-Jan Boons
Journal:  Org Biomol Chem       Date:  2008-07-25       Impact factor: 3.876

8.  Analysis of Expression and Localization of TLR-2 by Immunofluorescent Technique in Healthy and Inflammed Oral Tissues.

Authors:  Romaldin S D'Souza; Kishore G Bhat; D Sailaja; Deepa V Babji; Tushar K Bandiwadekar; Ramanand M Katgalkar
Journal:  J Clin Diagn Res       Date:  2013-12-15

9.  Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4.

Authors:  Richard P Darveau; Thu-Thao T Pham; Kayde Lemley; Robert A Reife; Brian W Bainbridge; Stephen R Coats; William N Howald; Sing Sing Way; Adeline M Hajjar
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Dendritic cells stimulated with Actinobacillus actinomycetemcomitans elicit rapid gamma interferon responses by natural killer cells.

Authors:  T Kikuchi; C L Hahn; S Tanaka; S E Barbour; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.